Dispensed, Prime, Healthcare, pharma, Biotech, gene therapy, merger, Mergers And Acquisitions, Health,

The top scientist at AveXis told us about this surprising reason that it got bought for $9 billion by Novartis, and it could shape the future of gene therapy

By

Hollis Johnson/Business Insider The biotech AveXis develops cutting-edge "gene therapy" products that could be powerful and long-lasting medical treatments.  Swiss drug giant Novartis bought the biotech for $9 billion last year in part because AveXis had figured out how to actually make gene therapies at a big-enough scale, AveXis Chief Scientific Officer Brian Kaspar told […]

MustHaves.LA a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites.